Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Working Toward Universal Connectivity in Drug Delivery

HealthPrize Technologies is teaming up again with West Pharmaceutical Services, Inc., to incorporate additional features into the system they developed a few years ago aimed at rewarding patient behavior that complied with their injectable drug regimen. The past three years have seen much success, but they have also seen continual evolution in patient reaction and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

HealthPrize Technologies is teaming up again with West Pharmaceutical Services, Inc., to incorporate additional features into the system they developed a few years ago aimed at rewarding patient behavior that complied with their injectable drug regimen.

The past three years have seen much success, but they have also seen continual evolution in patient reaction and adaptation to technology. In keeping with the pharma trend toward seeking holistic solutions, the new updates include an improve user interface, dedicated sales staff, and increased functionality for the West device and the HealthPrize platform.

In addition, the team have learned that they need to be more flexible and offer more choices to pharma companies. But the main goal for the second-generation device is increased connectivity. Keeping in mind the large amount of data potentially involved and the digitization of health records, it makes sense to aim for inoperability across platforms.

The HealthPrize platform interacts with patients using gamification, behavioral economics, and consumer marketing concepts. The goal of this ongoing collaboration, according to Chris Evans, vice president, global innovation at West, is to connect to any device, which could help achieve what he called “universal connectivity.”

Read more at MD+DI

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512